No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs552393908 |
chr20:16079095-16079096 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs187425846 |
chr20:16079159-16079160 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs531624128 |
chr20:16079164-16079165 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs192226983 |
chr20:16079172-16079173 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs775142 |
chr20:16079190-16079191 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs536154105 |
chr20:16079224-16079225 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs77108903 |
chr20:16079270-16079271 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs566153834 |
chr20:16079297-16079298 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs539978869 |
chr20:16079310-16079311 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs558381565 |
chr20:16079330-16079331 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs576854122 |
chr20:16079344-16079345 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs6034383 |
chr20:16079401-16079402 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs185529190 |
chr20:16079407-16079408 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs150802499 |
chr20:16079475-16079476 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs397966994 |
chr20:16079486-16079487 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs201360621 |
chr20:16079487-16079488 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs370885698 |
chr20:16079533-16079534 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs35570034 |
chr20:16079591-16079592 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs6105525 |
chr20:16079600-16079601 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs6105526 |
chr20:16079640-16079641 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs557743452 |
chr20:16079678-16079679 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs571206759 |
chr20:16079772-16079773 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs113006597 |
chr20:16079822-16079823 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs190398199 |
chr20:16079838-16079839 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs572168874 |
chr20:16079843-16079844 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs545948342 |
chr20:16079884-16079885 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs564457883 |
chr20:16079955-16079956 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs531818845 |
chr20:16079969-16079970 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs546125574 |
chr20:16080019-16080020 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs1885939 |
chr20:16080071-16080072 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs562056899 |
chr20:16080096-16080097 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs529266637 |
chr20:16080110-16080111 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs548115106 |
chr20:16080117-16080118 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs112012281 |
chr20:16080119-16080120 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs146184682 |
chr20:16080123-16080124 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs193293363 |
chr20:16080141-16080142 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs184257904 |
chr20:16080150-16080151 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs201908624 |
chr20:16080219-16080220 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs574570198 |
chr20:16080222-16080223 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs567721303 |
chr20:16080236-16080237 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs535055140 |
chr20:16080238-16080239 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs553797766 |
chr20:16080252-16080253 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs77539103 |
chr20:16080309-16080310 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs555827538 |
chr20:16080314-16080315 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs76333956 |
chr20:16080318-16080319 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs114068134 |
chr20:16080379-16080380 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs188259171 |
chr20:16080386-16080387 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs562121681 |
chr20:16080404-16080405 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs138881462 |
chr20:16080476-16080477 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs572708713 |
chr20:16080477-16080478 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|